DR. ARVIND NARASIMHAN MD NPI 1477597797

NPI Details

DR. Arvind Narasimhan, MD is an emergency medicine in Fort Washington, MD with 34 years of experience. The provider is an emergency physician focuses on the immediate decision making and action necessary to prevent death or any further disability both in the pre-hospital setting by directing emergency medical technicians and in the emergency department. The emergency physician provides immediate recognition, evaluation, care, stabilization and disposition of a generally diversified population of adult and pediatric patients in response to acute illness and injury. DR. Arvind Narasimhan, MD NPI is 1477597797. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:1992

The provider's business location address is:

11711 LIVINGSTON RD
FORT WASHINGTON, MD
ZIP 20744-151
Phone: (540) 364-2259
Fax: (540) 364-6033

The NPI 1477597797 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Emergency department visit for life threatening or functioning severity (HCPCS:99285)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Automated urinalysis test (HCPCS:81003)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Emergency department visit for problem of high severity (HCPCS:99284)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Administration of vaccine (HCPCS:90471)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• X-ray of chest, 2 views (HCPCS:71046)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• Myoglobin (muscle protein) level (HCPCS:83874)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12001)
• Emergency department visit for problem of moderate severity (HCPCS:99283)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/16/2006 and was last updated on 2/7/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.